直 Japanese PDF Font
  • 我们的专业人员
  • 服务
  • 我们的见解
  • 办公室
  • 事务所
  • 人才招聘
Finnegan
  • 新闻
  • 飞翰事实
  • History
    • Finnegan VISION
    • Finnegan FORWARD
  • 慈善性法律援助
  • 管理层
    • Pricing & Alternative Fee Arrangements
    • AFA Models We Offer
    • Contingency Fees
    • AI + KM

James R. Barney

PNC Bank Gets SPENDOLOGY Trademark Case Dismissed

November 24, 2015

Bloomberg BNA

On November 17, 2015, the U.S. District Court for the District of Maryland ruled in favor of Finnegan client PNC, prohibiting a mobile application developer from pursuing a trademark infringement claim against PNC for its use of the mark SPENDOLOGY. Since 2010, PNC has used the mark SPENDOLOGY for online budgeting tools. In 2011, the plaintiff filed an application to register SPENDOLOGY with the U.S. Patent & Trademark Office. PNC filed an opposition to the plaintiff’s application and in 2013, the Trademark Trial and Appeal Board (TTAB) found that PNC had in fact been using the mark before the plaintiff. More than a year after the deadline to appeal the TTAB decision had passed, the plaintiff filed a trademark infringement claim against PNC.

During that time, the Supreme Court handed down its decision in B&B Hardware, ruling that TTAB decisions on issues of likelihood of confusion could have issue preclusive effect. Given that decision, PNC filed a motion to dismiss the lawsuit on collateral estoppel grounds, arguing that the TTAB’s determination on priority should be accorded preclusive effect. The district court agreed, and dismissed the plaintiff’s lawsuit in its entirety. The decision is the first to apply the B&B Hardware ruling to issues of trademark priority.

Tags

Trademark Trial and Appeal Board (TTAB)

Related Practices

商标及品牌管理

Related Industries

电子与计算机技术

Related News

Commentary

Quince Aims to Have ‘Dupe’ Evidence Shape Ugg Shoe Patent Trial

May 26, 2026

Commentary

New Appellate Opinion in Amazon Biometric Data Case May Signal ‘Narrowing’ Scope of BIPA Litigation, Experts Say

May 20, 2026

Press Release

Finnegan Secures Decisive ITC Victory for Innoscience in Final Determination

May 11, 2026

Commentary

How Litigation Funding Disclosure Could Affect ITC Cases

May 7 , 2026

Award/Ranking

61 Finnegan Attorneys Recognized on the 2025 Capital Pro Bono Honor Roll

May 7, 2026

Commentary

Justices to Side with Generic Drugmakers in Patent Spat, Attorneys Predict

May 5, 2026

Award/Ranking

Finnegan Wins IP Firm of the Year at the 2026 LSPN Awards

May 1, 2026

Press Release

Finnegan Enhances Its German and European IP Practice with Björn Kalbfus

April 30, 2026

Commentary

Supreme Court Takes Up Generic Drug Labeling Fight

April 29, 2026

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • 隐私
  • 免责申明
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP